Biovista and its VP for Drug Discovery, Dr. Spyros Deftereos, MD, are featured in an online article in relation to CFIDS Association’s Research Institute Without Walls (RIWW)

The process of drug repurposing, also called “drug repositioning,” can slash the time and cost to bring new therapies to the patients who need them most, says Biovista vice president for drug discovery Spyros Deftereos, M.D., Ph.D.


Biovista is one of the leaders in the drug repurposing field. The Charlottesville, VA-based company has a systematic process that identifies the potential of existing, approved drugs for other medical conditions. As Biovista co-founder Aris Persidis, Ph.D., says, “A drug that is well seasoned is an excellent starting point for innovation.”

Read More…